Instructions for Authors

Thank you for your interest in Translational Clinical Research (TCR). Please consult the following instructions to help you prepare your manuscript. To ensure fast peer review and publication, manuscripts that do not adhere to the following instructions will be returned to the corresponding author for technical revision before undergoing peer review. Please feel free to contact us with any questions, and we are looking forward to your submission.

Cover Letter

A cover letter should be included with the submission. The letter can be entered directly into the field 'Comments to Editor' or uploaded as a file.

The cover letter must contain:
(1) A statement confirming the paper has not been published or submitted for publication elsewhere except as a brief abstract in a scientific meeting or symposium;
(2) An acknowledgment that all authors have contributed significantly and in keeping with the latest guidelines of the International Committee of Medical Journal Editors, each author’s contribution to the paper is to be described, i.e., what role each author participated in;
(3) a statement confirming that all authors are in agreement with the content of the manuscript.

(4) suggestions for reviewers

Suggest Reviewers

Authors could suggest three reviewers to the Editorial Office during the online submission. Reviewers will not know the author suggested them. Make sure that your suggestions are not current or recent colleagues of you or your co-authors. Complete names, affiliations and email addresses must be provided as missing information may lead to delays in initiating the peer review process.

Submission

TCR handles all manuscripts through the online peer review platform. When you are ready to submit your manuscript to TCR, please go to the submission page and use the Login/Register links to sign in or create an account. Once you are logged in, click the “Make a new submission” link and follow the step-by-step instructions. TCR requires that all authors are listed upon submission. To add additional authors, press “Add Contributor” (step 3 of the submission process: Enter metadata).

Once the article is submitted to TCR, it is reviewed by the assigned editor(s) for quality and relevance. All submitted manuscripts are checked for plagiarism. Articles are discussed at the monthly TCR board meeting and assessed by editors, who make the initial decision to send the article for peer review or reject it. If a manuscript is sent out for review, then based on the peer reviewers’ comments, the editors will discuss and make decision about the manuscript. Three outcomes can occur: rejection, conditional acceptance upon revision, and acceptance. Please note that if the article is conditionally accepted upon revision, it may undergo several rounds of revision until it meets TCR publication standards.

The Deputy Editors will correspond with the author regarding the publication decision and suggested edits. The goal of this interaction is to develop the article into a well-rounded manuscript. If it does not meet TCR standards by the required deadline for the issue for which it has been solicited, the article may not be published.

Once the article is accepted for publication, it will be sent to the Production Editor for copy editing, formatting, and copyright requests. Issues are published in February, May, August, and November and all articles will be made available online at the time of publication.

Manuscripts Turnaround Time:
In-house review: 3-5 days
External peer review: 1-2 months
Revision time: 1-3 weeks
Publication Ahead of Print: within 1 month after being accepted
Formal publication: within 1-2 months after being accepted.

Original Articles are listed as priority.

 

MANUSCRIPT CATEGORIES AND REQUIREMENTS

Ⅰ. Original Articles
Word limit: 5000 words maximum including abstract but excluding references, tables and figures.
Abstract: 450 words maximum, structured.
References: No limit.
Figures/tables: No limit, but 8 figures should be sufficient.
Description: Full-length reports of current research in either basic or clinical science. The abstract should contain the Background, Methods, Results and Conclusions. Original articles should entail a section describing the author contribution. Meta-analysis will be categorized into this type.

Ⅱ. Invited Reviews
Word limit: 6000 words maximum including abstract but excluding references, tables and figures.
Abstract: 450 words maximum, unstructured.
References: No limit.
Figures/tables: Minimum 1 image or figure.
Description: Reviews are comprehensive analyses of specific topics. They are submitted upon invitation by the Editors. Proposals for reviews may be submitted; however, in this case authors should only send an outline of the proposed paper for initial consideration. Both solicited and unsolicited review articles will undergo peer review prior to acceptance.

Ⅲ. Mini Reviews
Word limit: 4000 words maximum including abstract but excluding references, tables and figures.
Abstract: 300 words maximum, unstructured.
References: No limit.
Figures/tables: Maximum 4 images or figures.
Description: Mini Reviews are shorter reviews of topics that may be controversial or unresolved. They are submitted upon invitation by the Editors. Proposals for reviews may be submitted; however, in this case authors should only send an outline of the proposed paper for initial consideration. Both solicited and unsolicited review articles will undergo peer review prior to acceptance.

Ⅳ. Clinical Guidelines
Word limit: 6000 words maximum including abstract but excluding references, tables and figures.
Abstract: 300 words maximum, unstructured (no use of sub-headers).
References: no limit.
Figures/tables: minimum 1 image or figure.
Description: Guidelines need to be the product of a large group of individuals who are recognized authorities in their field. Guidelines will be written by a working party to include a steering committee (usually at least 4 members) and other authors representing a wide range of those with special relevant expertise and those whose everyday practice will be influenced by the guidelines.

Ⅴ. Images in Pediatric Medicine
Word limit: 350 words excluding references, tables and figures.
Abstract: Not required.
References: 3 maximum.
Figures: maximum 2 still images.
Description: Figures which are unique or highly illustrative of specific features in pediatric clinics. They will be reviewed by the Editors prior to acceptance, but they do not have to go out for external peer review.

Ⅵ. Letters to the Editor
Word limit: 500 words maximum.
Abstract: Not required.
References: 4 maximum.
Figures/tables: 1 maximum.
Description: Letters must offer perspective to content published in TCR or on other topics of interest. A Letter must reference the original source, and a Response to a Letter must reference the Letter in the first few paragraphs. Letters can use an arbitrary title, but a Response must cite the title of the Letter: e.g. Response to [title of Letter]. This ensures that readers can track the line of discussion. Letters to the Editor are not subjected to peer-review. Submissions may be edited for length, grammatical correctness, and journal style. Authors will be asked to approve editorial changes that alter the substance or tone of a letter or response.

Ⅶ. Editorials
Word Limit: 2000 words maximum.
Abstract: Not required.
References: 5 maximum.
Figures/tables: 2 maximum.
Description: Proposals for Editorials may be submitted; however, in this case authors should only send an outline of the proposed paper for initial consideration.

Ⅷ. Editorial Commentaries
Word limit: 2000 words maximum excluding references.
Abstract: not required.
References: 20 maximum, including the article discussed.
Figures/tables: 2 maximum.
Description: Commentaries, upon Editor’s invitation, discuss a paper published in a specific issue and should set the problems addressed by the paper in the wider context of the field. Proposals for Commentaries may be submitted; however, in this case authors should only send an outline of the proposed paper for initial consideration.

Ⅸ. Case Reports
Word limit: 3000 words maximum including abstract but excluding references, tables and figures.
Abstract: 300 words, unstructured.
References: 20 maximum.
Figures/tables: 4 maximum.
Description: New observations of diseases, clinical findings or novel/unique treatment outcomes relevant to practitioners in thoracic cancer. The text should be arranged as follows: Introduction, Case Report, and Discussion. Only cases of exceptional interest and novelty are considered. For manuscripts that do not qualify, Editors may ask authors to shorten manuscripts and rewrite as Letters to the Editor.

Ⅹ. Meeting Reports
Word limit: 3000 words maximum including abstract but excluding references, tables and figures.
Abstract: 300 words maximum, unstructured.
References: No limit.
Figures/tables: No limit, but 8 figures should be sufficient.
Description: Brief reports of symposia and conferences in cancer research. Reports must be submitted within 2 months of the meeting date in order to maintain their timeliness. Only those Meeting Reports dealing with topics of interest to the readership and that contain novel information and insights from the meeting are accepted for publication. A Meeting Report should be a thoughtful, critical commentary which shows an appreciation of the connections among the various presentations and reveals the consensus, if any, which emerged at the meeting. Before submitting a full Meeting Report, authors should only send an outline of the proposed paper for initial consideration.

Ⅺ. Technical Notes
Word limit: 1500 words including abstract but excluding references, tables and figures.
Abstract: 300 words, unstructured.
References: 35 maximum.
Figures/tables: 4 maximum in total.
Description: Technical notes articles should present a new experimental or improved method, test or procedure. The method described may either be completely new, or may offer a better version of an existing method. The article must describe a demonstrable advance on what is currently available. The method needs to have been well tested and ideally, but not necessarily, used in a way that proves its value.

Ⅻ. Study Protocols
Word limit: 5000 words maximum including abstract but excluding references, tables and figures.
Abstract: 300 words maximum, structured.
Registration details: Trial registration number and date of registration should be included as the last line, if appropriate.
References: No limit.
Figures/tables: No limit, but 8 figures should be sufficient.
Description: Protocol papers should report planned or ongoing studies. Manuscripts describing long term studies and those likely to generate a considerable amount of outcome data are given preference. The following protocol papers are not considered: (a) Authors have other articles relating to the protocol published or under consideration. (b) Protocol papers without ethics approval.

Peer Review: TCR will consider publishing without peer review protocols that have formal ethics approval and a grant from a recognized major funding body. Please provide proof that these criteria are met when uploading your protocol. Manuscripts without major external funding, or where the Editor considers it necessary, will be peer reviewed. The final decision on whether to consider a study protocol for publication will rest with the Editor.

Randomized trials: Protocols of randomized trials should follow the SPIRIT guidelines, including the SPIRIT flow diagram in the main body of the text, with the populated checklist provided as an additional file.

 

PREPARING THE SUBMISSION

Ⅰ. STYLE OF THE MANUSCRIPT
Manuscripts must follow the style of the Vancouver agreement detailed in the International Committee of Medical Journal Editors’ revised Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication.

Format: The main text file should be prepared using Microsoft Word using 1.5 line spacing. All pages should be numbered consecutively in the top right-hand corner, beginning with the first page of the main text file.

Spelling: The journal uses US spelling and authors should therefore follow the latest edition of the Merriam–Webster’s Collegiate Dictionary.

Units: All measurements must be given in SI or SI-derived units. For more information about SI units, please go to the Bureau International des Poids et Mesures (BIPM) website at: http://www.bipm.fr/

Abbreviations: Must be used sparingly – only where they ease the reader’s task by reducing repetition of long, technical terms. Initially use the word in full, followed by the abbreviation in parentheses. Thereafter use the abbreviation only.

Trade names: Drugs should be referred to by their generic names. If proprietary drugs have been used in the study, refer to these by their generic name, mentioning the proprietary name, and the name and location of the manufacturer, in parentheses.

Ⅱ. PARTS OF THE MANUSCRIPT
To facilitate the reivew process, no tables, figures and legends have been uploaded separately. On the contrary, the author should provide a complete manuscript file, incl. a title page, and with all tables, figures and legends placed at the end of the manuscript, following the references.

The title page should contain:
(1) The title and running title (less than 40 characters) of the paper. Concise titles are easier to read than long, convoluted ones. Authors should include all information in the title that will make electronic retrieval of the article both sensitive and specific.
(2) The full names of the authors;
(3) The addresses of the institutions at which the work was carried out;
(4) The full postal and email address of the author to whom correspondence about the manuscript should be sent.

Author name
Each author’s given name should be followed by family name. Capitalize each letter of the family name.
Hyphens can be used in the family name according to the rules use in the author’s region.
Capitalize the first letter of those words/syllables that they hope to be abbreviated in their given name, otherwise, DO NOT capitalize the first letter and use a hyphen to connect it with its anterior word.

Main Text File
The main text file should be presented in the following order:
(1) Title;
(2) Abstract;
(3) Key Words;
(4) Text;
(5) Author Contribution
(6) Acknowledgments;
(7) Disclosure;
(8) Ethical Statement
(9) References;
(10) Tables (each table complete with title and footnotes);
(11) Figure Legends.

Figures can be uploaded separately if they are large in size. Supplementary material should be supplied as separate files.

Abstract
The length of abstracts must adhere to the word count specifications under the section Manuscript Categories. The abstract should state the main problem, methods, results, and conclusions. It must be factual and comprehensive.

Key Words
Three to five key words should be supplied below the abstract, in alphabetical order, and should be taken from those recommended by the US National Library of Medicine’s Medical Subject Headings (MeSH) browser list.

Text
Authors should use the subheadings required for the Article Type as specified in the section ‘Manuscript Categories’. Original Article manuscripts should be structured using the following sections: Introduction, Methods, Results, Discussion.

Author Contributions
This section is only required for original article, review article, systematic review and meta-analysis article. It describes the contribution each author made to the manuscript. Authorship credit should be based on:
(1) substantial contributions to conception and design, acquisition of data, or analysis and interpretation of data;
(2) drafting the article or revising it critically for important intellectual content;
(3) final approval of the version to be published.

Authors should meet all three conditions mentioned above. Please note that acquisition of funding, collection of data, language editing or general supervision of the research group alone does not constitute authorship.

The Author Contributions section should be completed as follow:
(1) Conception and design;
(2) Administration support;
(3) Provision of study materials or patients;
(4) Collection and assembly of data;
(5) Data analysis and interpretation;
(6) Manuscript wiring: All authors;
(7) Final approval of manuscript: All authors

Acknowledgements
This should include sources of support/funding, including national and industry support. All authors who have contributed to the manuscript must be acknowledged any national and industry support/funding received. Medical writers, proofreaders and editors should not be listed as authors, but acknowledged here in the acknowledgements section.

Disclosure
All articles must include a disclosure statement. The statement should disclose all potential conflicts of interest, including specific financial interests and relationships and affiliations relevant to the subject of their manuscript. Authors without conflicts of interest should include a statement of no such interests in the Disclosure section of the manuscript.

Ethical Statement
The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. Please note that the above statement must be included as part of the Ethical Statement.

References
The AMA system of referencing should be used. In the text, references should be cited using superscript Arabic numerals in the order in which they appear. If cited in tables or figure legends, number according to the first identification of the table or figure in the text. In the reference list, cite the names of all authors when there are three or fewer; when four or more, list the first three followed by et al. Do not use ibid, or op cit. Reference to unpublished data and personal communications should not appear in the list but should be cited in the text only (e.g. Smith A, 2000, unpublished data). All citations mentioned in the text, tables or figures must be listed in the reference list. Names of journals should be abbreviated in the style used in PubMed. Authors are responsible for the accuracy of the references.

Journal article
Mello MM, Frakes MD, Blumenkranz E, Studdert DM. Malpractice Liability and Health Care Quality: A Review. JAMA. 2020;323(4):352–366. doi:10.1001/jama.2019.21411

Online article not yet published in an issue
An online article that has not yet been published in an issue can be cited by its Digital Object Identifier (DOI). The DOI will remain valid and allow an article to be tracked even after its allocation to an issue.

Koestenberger M, Avian A, Chouvarine P, et al. Right ventricular end-systolic remodeling index in the assessment of pediatric pulmonary arterial hypertension. The European Pediatric Pulmonary Vascular Disease Network (EPPVDN). Pediatr Res 2020. doi: 10.1038/s41390-020-0748-2.

Book
3 Ernstoff M. Urologic Cancer. Blackwell Science, Boston 1997.

Chapter in a book
4 Gilchrist RK. Further commentary: Continent stroma. In: King LR, Stone AR, Webster GD (eds). Bladder Reconstruction and Continent Urinary Diversion. Year Book Medical, Chicago 1987; 204-5.

Tables
Tables should be self-contained and complement, but not duplicate, information contained in the text. Number tables consecutively in the text in Arabic numerals. Type tables on a separate page with the legend above. Legends should be concise but comprehensive. Vertical lines should not be used to separate columns. Column headings should be brief, with units of measurement in parentheses; all abbreviations must be defined in footnotes. Footnote symbols: †, ‡, §, ¶, should be used (in that order) and * should be reserved for P-values. Statistical measures such as SD or SEM should be identified in the headings.

Figure legends
Type figure legends on a separate page after References or Tables if the manuscript includes them. Legends should be concise but comprehensive – the figure and its legend must be understandable without reference to the text. Include definitions of any symbols used and define/explain all abbreviations and units of measurement.

Figures
All illustrations (line drawings and photographs) are classified as figures. Figures should be cited in consecutive order in the text. Magnifications should be indicated using a scale bar on the illustration.
Size: Figures should be sized to fit within the column (82 mm), intermediate (118 mm) or the full text width (173 mm).
Resolution: Figures must be supplied as high resolution saved as .eps or .tif. Halftone figures 300 dpi (dots per inche), Color figures 300 dpi saved as CMYK, figures containing text 400 dpi, Line figure 1,000 dpi.
Color figures: Figures should be set up as CMYK (cyan, magenta, yellow, black) and not as RGB (red, green, blue) so that colors as they appear on screen will be a closer representation of how they will print in the journal.
Line figures: Must be sharp, black and white graphs or diagrams, drawn professionally or with a computer graphics package.
Text sizing in figures: Lettering must be included and should be sized to be no larger than the journal text or 8 point (Should be readable after reduction – avoid large type or thick lines). Line width between 0.5 and 1 point.
Although authors are encouraged to send the highest-quality figures possible, for peer-review purposes, a wide variety of formats, sizes, and resolutions are accepted.

Videos
TCR will accept digital files in mp4, flash video (flv.), MPEG (MPEG video file), DVD video format, mov., avi., and mwv. Submit your multimedia files directly online as part of your submission (select Multimedia in the dropdown list of components). If the files are too large for our file size limint, authors may send them to our editorial office via www.wetransfer.com. For fast uploads please attach your file(s) as compressed zip. files. Before submit your multimedia files, please check the following points.

Duration: All video files limited to 20 minutes.
Quality: Please set the video aspect ratio as 4:3 or 16:9 (widescreen). The original video should be of high quality. The resolution is no less than 1280×720, the frame rate no less than 24 frames per second and the bit rate no lower than 5Mbps.
Text in video: All the text notes, explanations or descriptions, etc. in the video must be in English. And the logo or watermark of hospital should not be stick on the screen. Plus, the information of patients should be erased from the video.
Video legends: The legends for the video should be provided. The video should be number consecutively in the order of reference in the text.
Once upload has been initiated, do not close the window until you have received on screen confirmation that your upload has been successful. Please note that the maximum size of each file has a limit of 2GB. If your file(s) for submission are greater than this limit, please divide the file into multiple segments, with the file names labeled in the correct order.

Equations
Equations should be numbered sequentially with Arabic numerals; these should be ranged right in parentheses. All variables should appear in italics. Use simples possible form for all mathematical symbols.

Supplementary Material
Supplementary material is not essential to the article, but it provides greater depth and background. Supplementary material must be submitted together with the article for review; they should not be added at a later stage. It is hosted online and appears without editing or typesetting. It may include tables, figures, videos, datasets, etc. The materials will be published as they are supplied and will not be checked or typeset in any way. All Supplementary material files should come with a legend, listed at the end of the main article.

 

ETHICAL CONSIDERATIONS

Authorship and Acknowledgements
The TCR adheres to the definition of authorship set up by The International Committee of Medical Journal Editors (ICMJE). The ICMJE recommends that authorship be based on the following 4 criteria:
(1) Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work;
(2) Drafting the work or revising it critically for important intellectual content;
(3) Final approval of the version to be published;
(4) Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Contributors who do not qualify as authors should be mentioned under ‘Acknowledgements’.

Informed Consent
Editors must protect the confidentiality of individual information (e.g. that obtained through the doctor–patient relationship). It is therefore almost always necessary to obtain written informed consent from patients described in case reports, original/research articles, visualized surgery, and for photographs of patients. It may be possible to publish without explicit consent if the report is important to public health (or is in some other way important); consent would be unusually burdensome to obtain; and a reasonable individual would be unlikely to object to publication (all three conditions must be met).

Conflict of Interest
Translational Clinical Research complies with the International Committee of Medical Journal Editors’ uniform requirements on Conflict of Interest statement.
Conflict of Interest exists when an author (or the author’s institution), reviewer, or editor has financial or personal relationships with other persons and/or organizations that inappropriately influence (bias) his or her actions. The existence of such relationships does not necessarily represent true conflict of interest. The potential for conflict of interest can exist when an individual believes that the relationship affects their judgment. Financial relationships (such as employment, consultancies, stock ownership, honoraria, paid expert testimony, patents) are the most easily identifiable conflicts of interest and the most likely to undermine the credibility of the journal, the authors, and of science itself (http://www.icmje.org/index.html).

Human Studies and Subjects
For manuscripts reporting medical studies that involve human subjects, a statement identifying the ethics committee that approved the study and confirmation that the study conforms to recognized standards is required, for example: Declaration of Helsinki; US Federal Policy for the Protection of Human Subjects; or European Medicines Agency Guidelines for Good Clinical Practice. It should also state clearly in the text that all persons gave their informed consent prior to their inclusion in the study.
Patient anonymity should be preserved. Photographs need to be cropped sufficiently to prevent human subjects being recognized (or an eye bar should be used). Images and information from individual participants will only be published where the authors have obtained the individual’s free prior informed consent. Authors do not need to provide a copy of the consent form to the publisher; however, in signing the author license to publish, authors are required to confirm that consent has been obtained.

Use of Animals in Research
A statement indicating that the protocol and procedures employed were ethically reviewed and approved, as well as the name of the body giving approval, must be included in the manuscript. Authors are encouraged to adhere to animal research reporting standards, for example the ARRIVE guidelines for reporting study design and statistical analysis; experimental procedures; experimental animals and housing and husbandry. Authors should also state whether experiments were performed in accordance with relevant institutional and national guidelines for the care and use of laboratory animals.

Clinical Trial Registration
The TCR journal requires that clinical trials are prospectively registered in a publicly accessible database and clinical trial registration numbers should be included in all papers that report their results. Authors are asked to include the name of the trial register and the clinical trial registration number at the end of the abstract. If the trial is not registered, or was registered retrospectively, the reasons for this should be explained.

We do not advocate one particular registry, but registration must be with a registry that meets the following minimum criteria:
(1) accessible to the public at no charge;
(2) searchable by standard, electronic (Internet-based) methods;
(3) open to all prospective registrants free of charge or at minimal cost;
(4) validates registered information;
(5) identifies trials with a unique number;
(6) includes information on the investigator(s), research question or hypothesis, methodology, intervention and comparisons, eligibility criteria, primary and secondary outcomes measured, date of registration, anticipated or actual start date, anticipated or actual date of last follow-up, target number of subjects, status (anticipated, ongoing or closed) and funding source(s).

Registries that currently meet these criteria include:
(1) the registry sponsored by the United States National Library of Medicine;
(2) the International Standard Randomized Controlled Trial Number Registry;
(3) the Australian New Zealand Clinical Trials Registry (ANZCTR);
(4) the Chinese Clinical Trials Register;
(5) the Clinical Trials Registry - India.

Randomized control trials
Reporting of randomized controlled trials should follow the guidelines of The CONSORT Statement.
Protocols of randomized trials should follow the SPIRIT guidelines, including the SPIRIT flow diagram in the main body of the text, with the populated checklist provided as an additional file.
Reproduction of Copyright Material
If excerpts from copyrighted works owned by third parties are included, credit must be shown in the contribution. It is the author’s responsibility to also obtain written permission for reproduction from the copyright owners.

Publication Ethics
This journal is a member of the Committee on Publication Ethics (COPE). Note this journal uses iThenticate’s CrossCheck software to detect instances of overlapping and similar text in submitted manuscripts.

Author Licencing 

TCR is an Open Access journal, so authors or their funding body pay an Article Processing Charge and publish their article under the copyright terms of a Creative Commons Attribution 4.0 International (CC BY 4.0) License. Creative Commons provides a simple, standardized way to grant copyright and sharing permissions to your article. This makes it easier for readers to know exactly how your article can be distributed, remixed, shared, sold, etc.

PUBLICATION PROCESS AFTER ACCEPTANCE

Accepted article received in production
When an accepted article is received by TCR production team, the corresponding author will receive an email asking them to pay the Article Publication Charge at this point.

Article processing charges
There is NO article submission charges. All articles published by TCR are fully open access: immediately freely available to read, download and share. To cover the cost of publishing, TCR charges a publication fee $700. All invited articles are free of charge.

Article-processing charges pay for:
(1) Immediate, worldwide open access to the full article text.
(2) Developing and maintaining electronic tools for peer review and publication
(3) Preparation in various formats for print & online publication
(4) Securing inclusion in Google Scholar, etc., enabling electronic citation in other journals that are available electronically

TCR is paid by Paypal. To properly credit your account, the following information must be included in the “comments” section of the payment: TCR APC Service + Your Full Name + Manuscript ID.
After payment, please send back a PAYMENT PROOF (screenshot) hopefully within one week. Order will be processed only after the payment is received.

Proofs
Once the paper is typeset, the author will receive an email notification with full instructions on how to provide proof corrections. It is essential that corresponding authors supply an email address to which correspondence can be emailed while their article is in production. Notification of the URL from where to download a Portable Document Format (PDF) typeset page proof, associated forms and further instructions will be sent by email to the corresponding author. The purpose of the PDF proof is a final check of the layout, and of tables and figures. Alterations other than the essential correction of errors are unacceptable at PDF proof stage. The proof should be checked, and approval to publish the article should be emailed to the Publisher by the date indicated, otherwise, it may be signed off by the Editor or held over to the next issue. Acrobat Reader will be required in order to read the PDF. This software can be downloaded (free of charge) from the following Web site:
http://www.adobe.com/products/acrobat/readstep2.html
This will enable the file to be opened, read on screen, and corrections to be added directly in the PDF. Further instructions will be sent with the proof.

Epub ahead of print (accepted articles)
TCR offers Accepted Articles service for selected articles. Accepted Articles are complete full-text articles published online in advance of their publication in a printed issue. Articles are therefore available as soon as they are ready, rather than having to wait for the next scheduled print issue. Accepted Articles have been fully reviewed and approved correction. The early view article is fully citable and carries an online publication date and Digital Object Identifier (DOI) for citations. After print publication, the DOI remains valid and can continue to be used to cite and access the article.

POST PUBLICATION

Access
When the article is published online the author receives an email alert with a direct link to the article. Authors are encouraged to share the article to anyone who might be interested in reading it.

Printed Offprints and hard copies
Printed offprints may be ordered online for a fee. Minimum orders of 100 offprints will be provided upon request, at the author’s expense. If you have queries about offprints and hard copies, please email: xxxxxxx.

DATA SHARING POLICY

Translational Clinical Research promotes and allows you to share data that supports the publication of studies when necessary and allows you to interlink the data with your published articles. Research data refers to the results of the observations or experimentation that confirm the research findings. The journal promotes the writers of articles published in our journal to share their research data including, but not limited to raw data, processed data, software, algorithms, protocols, models, methods and other related materials.
To follow the policy, you can link your article directly to the dataset if you have made your study data accessible in a data repository. Meanwhile, TCR encourages writers to provide their manuscript with a data statement. Data sharing statements may indicate whether individual de-identified participant data (including data dictionaries) will be shared (“undecided” is not an acceptable answer) or what data will be shared. Also it may indicate whether additional, related documents will be available (e.g., study protocol, statistical analysis plan, etc.) as well as when the data will become available and for how long and by what access criteria data will be shared (including with whom, for what types of analyses, and by what mechanism).

DIGITAL ARCHIVING POLICY

Digital preservation service was provided by PORTICO, which is part of the non-profilt organization ITHAKA (www.ithaka.org).

EDITORIAL OFFICE CONTACT DETAILS

Oxygenlink Publishing Company Limited
Peng Li
Managing Editor
Translational Clinical Research
Address: Unit 1420B, 14/F, the Belgian Bank Building, Nos. 721-725 On Nathan Road, Mongkok, Kowloon, Hong Kong
Phone: +852-21520278
Email: xxxxxx